[Prevention of post-operative recurrence in Crohn's disease: a critical review of randomized controlled trials and meta-analyses of different therapeutic strategies].
Giovanna Margagnoni, Valeria Clemente, Annalisa Aratari, Federica Fascì Spurio, Angela Maria De Gregorio, Annalisa Spagnolo, Maurizio Koch, Claudio Papi
Index: Recenti Prog. Med. 104(4) , 168-76, (2013)
Full Text: HTML
Abstract
Surgery is an almost inevitable event in Crohn's disease but is not curative; post-operative recurrence follows a sequential and predictable course. Prevention of post-operative recurrence in Crohn's disease is therefore a relevant problem in the management of the disease. Several drugs have been evaluated to decrease the risk of recurrence: these include mesalazine, antibiotics, probiotics, budesonide, thiopurines and biologic agents. This review focuses on the randomised controlled trials and meta-analyses addressing different drugs and strategies for preventing post-operative recurrence in Crohn's disease.
Related Compounds
Related Articles:
2010-01-01
[Chem. Res. Toxicol. 23 , 171-83, (2010)]
2011-12-01
[J. Sci. Ind. Res. 65(10) , 808, (2006)]
2015-02-01
[Biomed. Chromatogr. 29(2) , 261-7, (2015)]
A new approach for automated liquid-liquid extraction in a sequential injection manifold.
2015-01-01
[Anal. Bioanal. Chem 407(2) , 521-8, (2015)]
2008-06-12
[J. Med. Chem. 51 , 3275-87, (2008)]